Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00325026 · ClinicalTrials.gov registry record · Phase 2

Randomized Trial Comparing Misoprostol and Foley Bulb for Labor Induction in the Preterm Gestation

A Phase 2 study of Premature Birth and Cervical Ripening, sponsored by University of Florida.

Completed
Registry status
Phase 2
Development phase
130
Enrollment target
1
Study location

NCT00325026 is a Phase 2 study of Premature Birth and Cervical Ripening that has completed, run by University of Florida. The registered enrollment target is 130 participants, below the 391-participant average among 38 other Premature Birth trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00325026, a Phase 2 study of Premature Birth and Cervical Ripening, has completed, sponsored by University of Florida.

COMPLETED
Registry status
Phase 2
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the time to delivery of two different cervical ripening methods on the preterm gestation.

Interventions

  • DRUG Misoprostol
  • DEVICE Foley bulb

Study Locations (1)

Florida

  • Shands Hospital at the University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2005-04
Est. Completion 2007-04
Phase Phase 2

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT00325026

The ClinicalTrials.gov registry entry for NCT00325026 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 391-participant average among 38 other Premature Birth trials with a reported enrollment target (67% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Premature Birth appearing as the primary indexed condition, and to 2 interventions - of which Misoprostol is the first listed.

NCT00325026 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT00325026 about?

NCT00325026 is a clinical study titled "Randomized Trial Comparing Misoprostol and Foley Bulb for Labor Induction in the Preterm Gestation". The purpose of this study is to compare the time to delivery of two different cervical ripening methods on the preterm gestation.

What is the current status of trial NCT00325026?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 130 participants. The study started on 2005-04. Estimated completion is 2007-04.

What conditions does trial NCT00325026 study?

This clinical trial studies the following conditions: Premature Birth, Cervical Ripening.

What interventions are being tested in trial NCT00325026?

The interventions under investigation include: Misoprostol (DRUG), Foley bulb (DEVICE).

Who is sponsoring clinical trial NCT00325026?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00325026 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Premature Birth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.